Consensus on diagnosis and treatment of sudden hearing loss;Consenso sobre el diagnóstico y tratamiento de la sordera subita

Acta Otorrinolaringologica Espanola

Volumn 62, Issue 2, 2011, Pages 144-157

  Plaza, Guillermo ^a   Durio, Enrique ^b   Herráiz, Carlos ^c   Rivera, Teresa ^d   García Berrocal, José Ramón ^e  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Acoumetry; Adverse effects; Audiometry; Corticoids; Idiopathic sudden sensorineural hearing loss

Indexed keywords

CALCIUM; CORTICOSTEROID; DEFLAZACORT; DEXAMETHASONE; DEZACOR; METHYLPREDNISOLONE; OMEPRAZOLE; PREDNISOLONE; PREDNISONA ALONGA; PREDNISONE; UNCLASSIFIED DRUG; VITAMIN D; ZAMENE;

AUDIOMETRY; CLINICAL PROTOCOL; CONSENSUS; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OTOSCOPY; PERCEPTION DEAFNESS; PROGNOSIS; SHORT SURVEY; SPEECH AUDIOMETRY; SUDDEN DEAFNESS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TYMPANOMETRY;

ADRENAL CORTEX HORMONES; ADULT; ANTIVIRAL AGENTS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHILD; DIAGNOSTIC IMAGING; DIAGNOSTIC TECHNIQUES, OTOLOGICAL; EAR, INNER; FOLLOW-UP STUDIES; HEARING LOSS, BILATERAL; HEARING LOSS, SUDDEN; HUMANS; META-ANALYSIS AS TOPIC; MICROCIRCULATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASODILATOR AGENTS; VIRUS DISEASES;

EID: 79952702395     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otorri.2010.09.001     Document Type: Short Survey

References (177)

1. Rauch S.D. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med. 2008, 359:833-840.
2. Schreiber B.E., Agrup C., Haskard D.O., Luxon L.M. Sudden sensorineural hearing loss. Lancet. 2010, 375:1203-1211.
3. O'Malley M.R., Haynes D.S. Sudden hearing loss. Otolaryngol Clin North Am. 2008, 41:633-649.
4. Hughes G.B., Freedman M.A., Haberkamp T.J., Guay M.E. Sudden sensorineural hearing loss. Otolaryngol Clin North Am. 1996, 29:393-405.
5. Wilson W.R. Why treat sudden hearing loss. Am J Otol. 1984, 5:481-483.
6. Fetterman B.L., Luxford W.M., Saunders J.E. Sudden bilateral sensorineural hearing loss. Laryngoscope. 1996, 106:1347-1350.
7. Weber PC. Sudden sensorineural hearing loss. In: UpToDate, Dechler DJ (Ed.), UpToDate, Waltham, MA, 2009.
8. De Kleyn A. Sudden complete or partial loss of function of the octavus system in apparently normal persons. Acta Otol. 1944, 32:407-429.
9. Tran Ba Huy P., Manach Y. Les Urgences en ORL. Conduite à tenir en Urgence face à une surdité bruaque. Rapport de la Société française dÓRL. 2002, 207-225.
10. Merchant S.N., Adams J.C., Nadol J.B. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2005, 26:151-160.
11. Teranishi M., Katayama N., Uchida Y., Tominaga M., Nakashima T. Thirty-year trends in sudden deafness from four nationwide epidemiological surveys in Japan. Acta Otolaryngol. 2007, 127:1259-1265.
12. Klemm E., Deutscher A., Mösges R. Aktuelle Stichprobe zur Epidemiologie des idiopathischen Hörsturzes. Laryngorhinootologie. 2009, 88:524-527.
13. Guillemany JM, García-Piñero A. Sordera Brusca. Jano 23-29 de noviembre 2007; n 1673: 42-5.
14. Chau J.K., Lin J.R., Atashband S., Irvine R.A., Westerberg B.D. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope. 2010, 120:1011-1021.
15. Merchant S.N., Durand M.L., Adams J.C. Sudden deafness: is it viral?. ORL J Otorhinolaryngol Relat Spec. 2008, 70:52-62.
16. Jourdy D.N., Donatelli L.A., Victor J.D., Selesnick S.H. Assessment of variation throughout the year in the incidence of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2010, 31:53-57.
17. García Berrocal J.R.G., Ramírez-Camacho R., Portero F., Vargas J.A. Role of viral and Mycoplasma pneumoniae infection in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2000, 120:835-859.
18. Kanemaru S., Fukushima H., Nakamura H., Tamaki H., Fukuyama Y., Tamura Y. Alpha-Interferon for the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 1997, 254:158-162.
19. Pitkaranta A., Julkunen I. Sudden deafness: lack of evidence for systemic viral infection. Otolaryngol Head Neck Surg. 1998, 118:397-399.
20. Stokroos R.J., Albers F.W., Tenvergert E.M. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. Acta Otolaryngol. 1998, 118:488-495.
21. Tucci D.L., Farmer J.C., Kitch R.D., Witsell D.L. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol. 2002, 23:301-308.
22. Uri N., Doweck I., Cohen-Kerem R., Greenberg E. Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2003, 128:544-549.
23. Westerlaken B.O., Stokroos R.J., Dhooge I.J., Wit H.P., Albers F.W. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol. 2003, 112:993-1000.
24. Zadeh M.H., Storper I.S., Spitzer J.B. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg. 2003, 128:92-98.
25. Capaccio P., Cuccarini V., Ottaviani F., Fracchiolla N.S., Bossi A., Pignataro L. Prothrombotic gene mutations in patients with sudden sensorineural hearing loss and cardiovascular thrombotic disease. Ann Otol Rhinol Laryngol. 2009, 118:205-210.
26. Marcucci R., Alessandrello Liotta A., Cellai A.P., Rogolino A., Berloco P., Leprini E., et al. Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss. J Thromb Haemost. 2005, 3:929-934.
27. Rudack C., Langer C., Stoll W., Rust S., Walter M. Vascular risk factors in sudden hearing loss. Thromb Haemost. 2006, 95:454-461.
28. Aimoni C., Bianchini C., Borin M., Ciorba A., Fellin R., Martini A., et al. Diabetes, Cardiovascular Risk Factors and Idiopathic Sudden Sensorineural Hearing Loss: A Case-Control Study. Audiol Neurootol. 2009, 15:111-115.
29. Ballesteros F., Alobid I., Tassies D., Reverter J.C., Scharf R.E., Guilemany J.M., et al. Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors?. Audiol Neurootol. 2009, 14:139-145.
30. Cadoni G., Scorpecci A., Cianfrone F., Giannantonio S., Paludetti G., Lippa S. Serum fatty acids and cardiovascular risk factors in sudden sensorineural hearing loss: a case-control study. Ann Otol Rhinol Laryngol. 2010, 119:82-88.
31. Mosnier I, Stepanian A, Baron G, Bodenez C, Robier A, Meyer B, and Thromboembolic Risk Factors in Idiopathic Sudden Sensorineural Hearing Loss: A Case-Control Study. Audiol Neurootol. 2010; 16:55-66.
32. Nagaoka J., Anjos M.F., Takata T.T., Chaim R.M., Barros F., Penido Nde O. Idiopathic sudden sensorineural hearing loss: evolution in the presence of hypertension, diabetes mellitus and dyslipidemias. Braz J Otorhinolaryngol. 2010, 76:363-369.
33. Sancho Alvarez A., de Nicolás López R., Sancho Calvo R.M. Sordera súbita y prolapso mitral. Acta Otorrinolaringol Esp. 1988, 39:281-283.
34. Vázquez R., Solanellas J., Alfageme I., et al. Mitral valve prolapse and sudden deafness. Int J Cardiol. 2008, 124:370-371.
35. Wiles N.M., Hunt B.J., Callanan V., Chevretton E.B. Sudden sensorineural hearing loss and antiphospholipid syndrome. Haematologica. 2006, 91(12 suppl):ECR46.
36. Punj J., Pandey R., Darlong V. Sensorineural hearing loss after general anaesthesia: 52 cases reported until now!. Anaesthesia. 2009, 64:226.
37. Pau H., Selvadurai D., Murty G.E. Reversible sensorineural hearing loss after non-otological surgery under general anaesthetic. Postgrad Med J. 2000, 76:304-306.
38. Herrero Agustín J., González Martín F.M., Pinilla Urraca M., Laguna Ortega D., de la Fuente Hernández R. Hemorragia coclear. Causa excepcional de sordera súbita sensorineural. Acta Otorrinolaringol Esp. 2002, 53:363-368.
39. Salomone R., Abu T.A., Chaves A.G., Bocalini M.C., Vicente Ade O., Riskalla P.E. Sudden hearing loss caused by labyrinthine hemorrhage. Braz J Otorhinolaryngol. 2008, 74:776-779.
40. Rosado W.M., Palacios E. Sudden onset of sensorineural hearing loss secondary to intralabyrinthine hemorrhage: MRI findings. Ear Nose Throat J. 2008, 87:130-131.
41. Lin H.C., Chao P.Z., Lee H.C. Sudden sensorineural hearing loss increases the risk of stroke: a 5-year follow-up study. Stroke. 2008, 39:2744-2748.
42. Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2009; 4:CD003422.
43. Yue W.L., Li P., Qi P.Y., Li H.J., Zhou H. Role of low-molecular-weight heparins in the treatment of sudden hearing loss. Am J Otolaryngol. 2003, 24:328-333.
44. Klingel R., Heibges A., Uygun-Kiehne S., Fassbender C., Mösges R. Rheopheresis for sudden sensorineural hearing loss. Atheroscler Suppl. 2009, 10:102-106.
45. Heigl F., Hettich R., Suckfuell M., Luebbers C.W., Osterkorn D., Osterkorn K., et al. Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients. Atheroscler Suppl. 2009, 10:95-101.
46. Julius U., Tselmin S., Fischer S., Passauer J., Bornstein S.R. The Dresden Apheresis Center - experience with LDL apheresis and immunoadsorption. Atheroscler Suppl. 2009, 10:12-16.
47. Mösges R., Köberlein J., Heibges A., Erdtracht B., Klingel R., Lehmacher W. Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol. 2009, 266:943-953. RHEO-ISHL Study Group.
48. Canis M., Suckfüll M. Rheopheresis as a successful second-line treatment for sudden hearing loss. HNO. 2010, 58:443-444.
49. Uygun-Kiehne S., Straube R., Heibges A., Klingel R., Davids H. Rheopheresis for recurrent sudden hearing loss: therapeutic options for patients refractory to infusion therapy. HNO. 2010, 58:445-451.
50. Cinamon U., Bendet E., Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol. 2001, 258:477-480.
51. Echarri R.M., Rivera T., Mate M.A., Cobeta I. Sordera súbita: eficacia de un protocolo terapéutico. Acta Otorrinolaringol Esp. 2000, 51:490-494.
52. Kim M.G., Jung Y.G., Eun Y.G. Effect of steroid, carbogen inhalation, and lipoprostaglandin E(1) combination therapy for sudden sensorineural hearing loss. Am J Otolaryngol 2009 Dec 18, [Epub ahead of print].
53. Aslan I., Oysu C., Veyseller B., Baserer N. Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness?. Otolaryngol Head Neck Surg. 2002, 126:121-126.
54. Cadoni G., Agostino S., Scipione S., Ippolito S., Caselli A., Marchese R., Paludetti G. Sudden sensorineural hearing loss: our experience in diagnosis, treatment, and outcome. J Otolaryngol. 2005, 34:395-401.
55. Bennett M., Kertesz T., Yeung P. Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss and tinnitus: a systematic review of randomized controlled trials. J Laryngol Otol. 2005, 119:791-798.
56. Horn C.E., Himel H.N., Selesnick S.H. Hyperbaric oxygen therapy for sudden sensorineural hearing loss: a prospective trial of patients failing steroid and antiviral treatment. Otol Neurotol. 2005, 26:882-889.
57. Dundar K., Gumus T., Ay H., Yetiser S., Ertugrul E. Effectiveness of hyperbaric oxygen on sudden sensorineural hearing loss: prospective clinical research. J Otolaryngol. 2007, 36:32-37.
58. Domachevsky L., Keynan Y., Shupak A., Adir Y. Hyperbaric oxygen in the treatment of sudden deafness. Eur Arch Otorhinolaryngol. 2007, 264:951-953.
59. Fujimura T., Suzuki H., Shiomori T., Udaka T., Mori T. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2007, 264:861-866.
60. Bennett MH, Kertesz T, Yeung P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev. 2007; 1:CD004739.
61. Cekin E., Cincik H., Ulubil S.A., Gungor A. Effectiveness of hyperbaric oxygen therapy in management of sudden hearing loss. J Laryngol Otol. 2009, 123:609-612.
62. Körpinar S., Alkan Z., Yiĝit O., Gör A.P., Toklu A.S., Cakir B., et al. Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol 2010 Jul 14, [Epub ahead of print].
63. Zhuo X.L., Wang Y., Zhuo W.L., Zhang X.Y. Is the application of prostaglandin E1 effective for the treatment of sudden hearing loss? An evidence-based meta-analysis. J Int Med Res. 2008, 36:467-470.
64. Suzuki H., Fujimura T., Shiomori T., Ohbuchi T., Kitamura T., Hashida K., et al. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx. 2008, 35:192-197.
65. García-Berrocal J.R., Ramírez-Camacho R., Millán I., Górriz C., Trinidad A., Arellano B., et al. Sudden presentation of immune-mediated inner ear disease: characterization and acceptance of a cochleovestibular dysfunction. J Laryngol Otol. 2003, 117:775-779.
66. García-Berrocal J.R., Trinidad A., Ramírez-Camacho R., Verdaguer J.M., Ibañez A. Immunologic work-up study for inner ear disorders: looking for a rational strategy. Acta Otolaryngol. 2005, 125:814-818.
67. Toubi E., Ben-David J., Kessel A., Halas K., Sabo E., Luntz M. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2004, 113:445-449.
68. García Callejo F.J., Velert Vila M.M., Laporta P., Orts Alborch M.H., de Paula Vernetta C., Marco Algarra J. Titulación de anticuerpos anticocleares mediante western-blot y grado de recuperación auditiva tras corticoterapia en pacientes con sordera súbita. Acta Otorrinolaringol Esp. 2004, 55:463-469.
69. Wilson H., Alderson D.J. Sudden sensorineural hearing loss: when is it idiopathic?. J Laryngol Otol. 2010, 124:690-693.
70. Goodhill V. Sudden deafness and window rupture. Laryngoscope. 1971, 81:1462-1474.
71. Simmons F.B. Theory of membrane breaks in sudden hearing loss. Arch Otolaryngol. 1968, 88:41-48.
72. Maier W., Fradis M., Kimpel S., Schipper J., Laszig R. Results of exploratory tympanotomy following sudden unilateral deafness and its effects on hearing restoration. Ear Nose Throat J. 2008, 87:438-451.
73. Gedlicka C., Formanek M., Ehrenberger K. Analysis of 60 patients after tympanotomy and sealing of the round window membrane after acute unilateral sensorineural hearing loss. Am J Otolaryngol. 2009, 30:157-161.
74. Yueh B., Shapiro N., MacLean C.H., Shekelle P.G. Screening and management of adult hearing loss in primary care: scientific review. JAMA. 2003, 289:1976-1985.
75. AEDA. Auditio: Revista Electrónica de Audiología. 2002. Disponible en (consultado a 24 de noviembre de 2009). http://www.auditio.com/.
76. Chen C.N., Young Y.H. Differentiating the cause of acute sensorineural hearing loss between Ménière's disease and sudden deafness. Acta Otolaryngol. 2006, 126:25-31.
77. Lobo D., López F.G., García-Berrocal J.R., Ramírez-Camacho R. Diagnostic tests for immunomediated hearing loss: a systematic review. J Laryngol Otol. 2008, 122:564-573.
78. Süslü N., Yilmaz T., Gürsel B. Utility of anti-HSP 70, TNF-alpha, ESR, antinuclear antibody, and antiphospholipid antibodies in the diagnosis and treatment of sudden sensorineural hearing loss. Laryngoscope. 2009, 119:341-346.
79. Gross M., Eliashar R., Ben-Yaakov A., Ulmansky R., Elidan J. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss. Audiol Neurootol. 2008, 13:231-238.
80. García-Berrocal J.R., Vargas J.A., Ramírez-Camacho R.A., González F.M., Gea-Banacloche J.C., Vergara J., Durántez A. Deficiency of naive T cells in patients with sudden deafness. Arch Otolaryngol Head Neck Surg. 1997, 123:712-717.
81. Weber P.C., Zbar R.I., Gantz B.J. Appropriateness of magnetic resonance imaging in sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 1997, 116:153-156.
82. Lin Y.T., Young Y.H. Retrocochlear mass lesion in mid-frequency sudden deafness. Otolaryngol Head Neck Surg. 2008, 138:13-17.
83. Nosrati-Zarenoe R., Hansson M., Hultcrantz E. Assessment of diagnostic approaches to idiopathic sudden sensorineural hearing loss and their influence on treatment and outcome. Acta Otolaryngol. 2010, 130:384-391.
84. Cadoni G., Cianfoni A., Agostino S., Scipione S., Tartaglione T., Galli J., et al. Magnetic resonance imaging findings in sudden sensorineural hearing loss. J Otolaryngol. 2006, 35:310-316.
85. Aarnisalo A.A., Suoranta H., Ylikoski J. Magnetic resonance imaging findings in the auditory pathway of patients with sudden deafness. Otol Neurotol. 2004, 25:245-249.
86. Chatard-Baptiste S., Martin C., Pouget J.F., Veyret C. Surdités brusques: intérèt de l'imagerie: à propos d'une étude prospective de 37 cas. J Radiol. 2009, 90:1823-1835.
87. Tran Ba Huy P., Sauvaget E. La surdité brusque idiopathique n'est pas, aujourd'hui, une urgence sensorielle. Ann Otolaryngol Chir Cervicofac. 2007, 124:66-71.
88. Sauvage JP, et al. Sorderas bruscas y fluctuantes. Enciclopedia Medico-Quirúrgica 2002; ed. Elsevier E-20-183-A-10.
89. Sugiura M., Naganawa S., Ishida I.M., Teranishi M., Nakata S., Yoshida T., et al. Vestibular aqueduct in sudden sensorineural hearing loss. J Laryngol Otol. 2008, 122:887-892.
90. Can I.H., Göçmen H., Kurt A., Samim E. Sudden hearing loss due to large vestibular aqueduct syndrome in a child: should exploratory tympanotomy be performed?. Int J Pediatr Otorhinolaryngol. 2004, 68:841-844.
91. Fushiki H., Junicho M., Aso S., Watanabe Y. Recurrence rate of idiopathic sudden low-tone sensorineural hearing loss without vertigo: a long-term follow-up study. Otol Neurotol. 2009, 30:295-298.
92. Fushiki H., Junicho M., Kanazawa Y., Aso S., Watanabe Y. Prognosis of sudden low-tone loss other than acute low-tone sensorineural hearing loss. Acta Otolaryngol. 2010, 130:559-564.
93. Finger R.P., Gostian A.O. Idiopathic sudden hearing loss: contradictory clinical evidence, placebo effects and high spontaneous recovery rate-where do we stand in assessing treatment outcomes?. Acta Otolaryngol. 2006, 126:1124-1127.
94. Jeyakumar A., Francis D., Doerr T. Treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2006, 126:708-713.
95. Alexiou C., Arnold W., Fauser C., Schratzenstaller B., Gloddek B., Fuhrmann S., et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense?. Arch Otolaryngol Head Neck Surg. 2001, 127:253-258.
96. Mattox D.E., Simmons F.B. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977, 86:463-480.
97. Byl F.M. Sudden hearing loss: eight years' experience and suggested prognosis table. Laryngoscope. 1984, 94:647-661.
98. Simmons F.B. Sudden idiopathic sensorineural hearing loss: some observations. Laryngoscope. 1973, 83:1221-1227.
99. Ceylan A., Celenk F., Kemaloĝlu Y.K., Bayazit Y.A., Göksu N., Ozbilen S. Impact of prognostic factors on recovery from sudden hearing loss. J Laryngol Otol. 2007, 121:1035-1040.
100. Chao T.K., Hsiu-Hsi Chen T. Predictive model for improvement of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2010, 31:385-393.
101. Cvorović L., Deric D., Probst R., Hegemann S. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008, 29:449-464.
102. Hikita-Watanabe N., Kitahara T., Horii A., Kawashima T., Doi K., Okumura S.I. Tinnitus as a prognostic factor of sudden deafness. Acta Otolaryngol. 2010, 130:79-83.
103. Conlin A.E., Parnes L.S. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg. 2007, 133:573-581.
104. Wei, B, Mubiru, S, O'leary, S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006; CD003998.
105. Shemirani N.L., Schmidt M., Friedland D.R. Sudden sensorineural hearing loss: An evaluation of treatment and management approaches by referring physicians. Otolaryngol Head Neck Surg. 2009, 140:86-91.
106. Conlin A.E., Parnes L.S. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg. 2007, 133:582-586.
107. Wilson W.R., Byl F.M., Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double blind clinical study. Arch Otolaryngol 1980, 106:772-776.
108. Moskowitz D., Lee K.J., Smith H.W. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope. 1984, 94:664-666.
109. Kitajiri S., Tabuchi K., Hiraumi H., Hirose T. Is corticosteroid therapy effective for sudden-onset sensorineural hearing loss at lower frequencies. Arch Otolaryngol Head Neck Surg. 2002, 128:365-367.
110. Chen C.Y., Halpin C., Rauch S.D. Oral steroid treatment of sudden onset sensorineural hearing loss: a ten tear retrospective analysis. Otol Neurotol. 2003, 24:728-733.
111. Slattery W.H., Fisher L.M., Iqbal Z., Liu N. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005, 132:5-10.
112. Arellano B., García Berrocal J.R., Górriz C., González F.M., Vicente J., Ramírez Camacho R. Protocolo de tratamiento de la sordera súbita. Acta Otorrinolaringol Esp. 1997, 48:513-516.
113. Pino Rivero V., Trinidad Ruíz G., Marcos García M., Montero García C., González Palomino A., Pantoja Hernández C.G., et al. Estudio estadístico y resultados clínicos de la comparación de dos protocolos diferentes en el tratamiento de la hipoacusia brusca. Acta Otorrinolaringol Esp. 2005, 56:63-67.
114. Hu A., Parnes L.S. Intratympanic Steroids for Inner Ear Disorders: A Review. Audiol Neurootol. 2009, 14:373-382.
115. Hamid M., Trune D. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg. 2008, 16:434-440.
116. Rauch S.D. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am. 2004, 37:1061-1074.
117. Parnes L.S., Sun A.H., Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999, 109:1-17.
118. Chandrasekhar S.S. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001, 22:1823.
119. Alles M.J., der Gaag M.A., Stokroos R.J. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol. 2006, 263:791-797.
120. Gianoli G.J., Li J.C. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg. 2001, 125:142-146.
121. Guan-Min H., Hung-Ching L., Min-Tsan S., Tsai H.T. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope. 2004, 114:1184-1189.
122. Gouveris H., Selivanova O., Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol. 2005, 262:131-134.
123. Herr B.D., Marzo S.J. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005, 132:527-531.
124. Battista R.A. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005, 132:902-905.
125. Choung Y.H., Park K., Shin Y.R., Cho M.J. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope. 2006, 116:747-752.
126. Dallan I., Bruschini L., Nacci A., Bruschini P., Traino C., Rognini F., et al. Transtympanic steroids as a salvage therapy in sudden hearing loss: preliminary results. ORL J Otorhinolaryngol Relat Spec. 2006, 68:247-252.
127. Kopke R.D., Hoffer M.E., Wester D., O'Leary M.J., Jackson R.L. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol. 2001, 22:475-479.
128. Lefebvre P.P., Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol. 2002, 122:698-702.
129. Lautterman J., Sudhoff, Junker R. Transtympanic corticoid therapy for acute profounf hearing loss. Eur Arch Otorhinolaryngol. 2005, 262:587-591.
130. Plontke S., Lowenheim H., Preyer S., Leins P., Dietz K., Koitschev A., et al. Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials. Acta Otolaryngol. 2005, 125:830-839.
131. Slattery W.H., Fisher L.M., Iqbal Z., Friedman R.A., Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg. 2005, 133:251-259.
132. Roebuck J., Chang C.Y. Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2006, 135:276-279.
133. Banerjee A., Parnes L.S. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol. 2005, 26:878-881.
134. Xenellis J., Papadimitriou N., Nikolopoulos T., Maragoudakis P., Segas J., Tzagaroulakis A., et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg. 2006, 134:940-945.
135. Kakehata S., Sasaki A., Oji K., Futai K., Ota S., Makinae K., et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol. 2006, 27:604-608.
136. Haynes D.S., O'Malley M., Cohen S., Watford K., Labadie R.F. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007, 117:3-15.
137. Fitzgerald D.C., McGuire J.F. Intratympanic steroids for idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2007, 116:253-256.
138. Van Wijck F., Staecker H., Lefebvre P.P. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol. 2007, 127:1012-1017.
139. Kara E., Cetik F., Tarkan O., Sürmelioĝlu O. Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2010, 267:701-707.
140. Hong S.M., Park C.H., Lee J.H. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg. 2009, 141:579-583.
141. Kiliç R., Safak M.A., Oĝuz H., Kargin S., Demirci M., Samim E., et al. Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol. 2007, 28:312-316.
142. Han C.S., Park J.R., Boo S.H., Jo J.M., Park K.W., Lee W.Y., et al. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg. 2009, 141:572-578.
143. Ahn J.H., Yoo M.H., Yoon T.H., Chung J.W. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?. Laryngoscope. 2008, 118:279-282.
144. Battaglia A., Burchette R., Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008, 29:453-460.
145. Plontke S.K., Lowenheim H., Mertens J., Engel C., Meisner C., Weidner A., et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2009, 119:359-369.
146. Zernotti M.E., Paoletti O.A., Zernotti M., Martínez M.E., Roques-Revol M., Prina A.C. Dexametasona intratimpánica como opción terapéutica en hipoacusia neurosensorial súbita. Acta Otorrinolaringol Esp. 2009, 60:99-103.
147. Lee H.S., Kim J.M., Kim Y.J., Chung D.H., Seo B.S., Kim S.H. Results of intratympanic dexamethasone injection as salvage treatment in idiopathic sudden hearing loss. J Otolaryngol Head Neck Surg. 2008, 37:263-268.
148. Plaza G., Herráiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg. 2007, 137:74-78.
149. Dallan I., De Vito A., Fattori B., Casani A.P., Panicucci E., Berrettini S., Marchetti M., et al. Intratympanic Methylprednisolone in Refractory Sudden Hearing Loss: A 27-Patient Case Series With Univariate and Multivariate Analysis. Otol Neurotol. 2010, 31:25-30.
150. Herraiz C., Aparicio J.M., Plaza G. La vía intratimpánica en el tratamiento de la patología de oído interno. Acta Otorrinolaringol Esp. 2010, 61:225-232.
151. She W., Dai Y., Du X., Yu C., Chen F., Wang J., Qin X. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2010, 142:266-271.
152. Deflazacort como glucocorticoide por vía oral. Insitut Catalá de Farmacología. 2002. Disponible en: (consultado a 24 de noviembre de 2009). http://www.icf.uab.es/HOSPITAL/informes/cast/2002/IPI802deflazacort-es.pdf.
153. Rhen T., Cidlowski J. Anti-inflammatory action of glucocorticoids: new mechanisms for old drugs. N Engl J Med. 2005, 353:1711-1723.
154. Aoki D., Takegoshi H., Kikuci S. Evaluation of super-highdose steroid therapy for sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2006, 134:783-878.
155. Westerlaken B.O., de Kleine E., van der, Laan B., Albers F. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial. Laryngoscope. 2007, 117:684-690.
156. Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. Guidelines on the prevention and treatment of glucocorticoid induced osteoporosis. Disponible en: (consultado a 24 de noviembre de 2009). http://www.rcplondon.ac.uk/pubs/books/glucocorticoid/-glucocortConcise.pdf.
157. Sosa Henriquez M. Grupo de Trabajo en Osteoporosis de la Sociedad Española de Medicina Interna. (GTO-SEMI). Guía de prevención y tratamiento de la osteoporosis inducida por corticoides. Disponible en: (consultado a 24 de noviembre de 2009). http://www.fesemi.org/grupos/osteoporosis/-publicaciones/guia_gio_semi.pdf.
158. García-Berrocal J.R., Ramírez-Camacho R., Lobo D., Trinidad A., Verdaguer J.M. Adverse effects of glucocorticoid therapy for inner ear disorders. ORL J Otorhinolaryngol Relat Spec. 2008, 70:271-274.
159. Buttgereit F., da Silva J.A., Boers M., Burmester G.R., Cutolo M., Jacobs J., et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002, 61:718-722.
160. Hoes J.N., Jacobs J.W., Verstappen S.M., Bijlsma J.W., Van der Heijden G.J. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis. 2009, 68:1833-1838.
161. Free R.H., Smale N.D., De Kleine E., Van Der Laan B.F.A.M. Side effects of oral dexamethasone pulse therapy for idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2009, 30:691.
162. Poetker D.M., Reh D.D. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am. 2010, 43:753-768.
163. Shaia F., Sheehy J. Sudden sensörineural hearing impairment: a report of 1220 cases. Laryngoscope. 1976, 86:389-398.
164. Probst R., Tschopp K., Lüdin E., Kellerhals B., Podvinec M., Pfaltz C.R. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol. 1992, 112:435-443.
165. Burschka M.A., Hassan H.A., Reineke T., van Bebber L., Caird D.M., Mösges R. Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol. 2001, 258:213-219.
166. Kronenberg J., Almagor M., Bendet E., Kushnir D. Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study. Laryngoscope 1992, 102:65-68.
167. Moon I.S., Kim J., Lee S.Y., Choi H.S., Lee W.S. How long should the sudden hearing loss patients be followed after early steroid combination therapy?. Eur Arch Otorhinolaryngol. 2009, 266:1391-1395.
168. Yeo S.W., Lee D.H., Jun B.C., Park S.Y., Park Y.S. Hearing outcome of sudden sensorineural hearing loss: long-term follow-up. Otolaryngol Head Neck Surg. 2007, 136:221-224.
169. Canis M., Osterkorn D., Osterkorn K., Suckfuell M. A Retrospective Assessment of 741 Patients with Sudden Hearing Loss. The Open Otorhinolaryngology Journal. 2009, 3:5-10. 5.
170. Psifidis A.D., Psillas G.K., Daniilidis JCh. Sudden sensorineural hearing loss: long-term follow-up results. Otolaryngol Head Neck Surg. 2006, 134:809-815.
171. Kallinen J., Laurikainen E., Bergroth L., Grénman R. A follow-up study of patients suffering from sudden sensorineural hearing loss. Acta Otolaryngol. 2001, 121:818-822.
172. Siegel L.G. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am. 1975, 8:467-473.
173. Yanagita N., Nakashima T., Ohno Y., Kanzaki J., Shitara T. Estimated Annual Number of Patients Treated for Sensorineural Hearing Loss in Japan Results of a Nationwide Epidemiological Survey in 1987. Acta Otolaryngol (Stockh). 1994, (Suppl 514):9-13.
174. Kanzaki J. Diagnostic Criteria for Acute Profound Deafness. Acta Otolaryngol (Stockh). 1994, (Suppl 514):7-8.
175. Kanzaki J., Inoue Y., Ogawa K., et al. Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx. 2003, 30:123-127.
176. Nosrati-Zarenoe R., Arlinger S., Hultcrantz E. Idiopathic sudden sensorineural hearing loss: results drawn from the Swedish national database. Acta Otolaryngol. 2007, 127:1168-1175.
177. Plontke S.K., Bauer M., Meisner C. Comparison of pure-tone audiometry analysis in sudden hearing loss studies: lack of agreement for different outcome measures. Otol Neurotol. 2007, 28:753-763.